Pharmacotherapy for Liver Cirrhosis and Its Complications (2022) Xingshun Qi

Description

A specialized text focusing on the pharmacotherapy required for treating liver cirrhosis and managing its associated complications. It addresses the growing worldwide morbidity and mortality rates of chronic liver disease, covering etiology factors such as alcohol, viral hepatitis B and C, metabolic dysfunction-associated fatty liver disease (MAFLD).